YUG-17524-62400
4 vaccinations
8 coded responses
44 check-ins
7 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 480 / MI
- Registered
- 2021-01-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Registered in v-safe
-
2021-01-05
Dose 1 — Moderna
- 2021-01-05
-
2021-01-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-06
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-07
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-08
- 2021-01-09
- 2021-01-11
- 2021-01-14
- 2021-01-19
- 2021-01-26
-
2021-02-01
Dose 2 — Moderna
-
2021-02-01
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Redness · Headache, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-02
Survey response — days 1–6 daily, dose 2MedDRA: Flushing, Immediate post-injection reaction, Rash, Rash macular — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesFree text: Rash is red blotches on face. Appeared about 30 minutes after injection and flushing.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-03
Survey response — days 1–6 daily, dose 2MedDRA: Rash — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesFree text: Facial bright red rash areas have not gone away from 1st day of vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Survey response — days 1–6 daily, dose 2MedDRA: Erythema, Hypersensitivity, Pre-existing disease, Rash macular — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Facial red blotches, have not gone away since day 1. Looks like a lupus flare and/ or allergic reaction I have had in past to a drug.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Survey response — days 1–6 daily, dose 2MedDRA: Rash, Rash macular — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Big Facial red blotches and rash from day one have not gone away!MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-08
Health check-in — day 7, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-16
- 2021-02-22
- 2021-08-02
-
2021-11-05
Dose 3 — Moderna
-
2021-11-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-10
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-11
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-12
Health check-in — day 7, dose 3Feeling: Fair · Site: Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-19
- 2021-11-26
-
2021-12-03
Survey response — day 28, dose 3MedDRA: Arthralgia, Ligament pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Joint and ligament painMedDRA releases: 2024-11 · check-in free text available
- 2021-12-10
- 2021-12-17
-
2022-02-06
Survey response — 3 months, dose 3MedDRA: Breast cancer — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Breast cancerMedDRA releases: 2024-11 · check-in free text available
-
2022-02-06
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-11
-
2022-03-31
Dose 4 — Moderna
-
2022-03-31
Health check-in — day 0, dose 4Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-01
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-02
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-03
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-05
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-06
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-08
Health check-in — day 7, dose 4Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-14
Survey response — day 14, dose 4MedDRA: Chest pain, Pleural effusion, Therapeutic aspiration, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Chronic pain in chest, Fluid buildup, aspiration left breast/chest · Healthcare visit (other): CT scanMedDRA releases: 2024-11 · check-in free text available
-
2022-04-14
Report sent to call center — day 14, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-19
Call successfulDoes not wish to fill out VAERS report
- 2022-04-21
- 2022-04-28
- 2022-05-06
- 2022-05-12
- 2022-06-30
-
2023-03-31
Survey response — 12 months, dose 4MedDRA: Breast cancer, Electrocardiogram QT prolonged — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationMedDRA releases: 2024-11
-
2023-03-31
Report sent to call center — 12 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
-
2023-04-03
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Moderna | |
| 2 | 2021-02-01 | Moderna | |
| 3 | 2021-11-05 | Moderna | No |
| 4 | 2022-03-31 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-06 | priority 2/3 | |
| 2021-01-07 | priority 2/3 | |
| 2022-02-06 | Successful | Does not wish to fill out VAERS report |
| 2022-04-14 | Successful 2022-04-19 |
Does not wish to fill out VAERS report |
| 2023-03-31 | Successful 2023-04-03 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Rash is red blotches on face. Appeared about 30 minutes after injection and flushing.
Systemic reaction (other): Facial bright red rash areas have not gone away from 1st day of vaccine
Systemic reaction (other): Facial red blotches, have not gone away since day 1. Looks like a lupus flare and/ or allergic reaction I have had in past to a drug.
Systemic reaction (other): Big Facial red blotches and rash from day one have not gone away!
Release 10 — day 28, dose 3
Symptoms: Joint and ligament pain
Release 11 — 3 months, dose 3
Symptoms: Breast cancer
Release 11 — day 14, dose 4
Symptoms: Chronic pain in chest, Fluid buildup, aspiration left breast/chest
Healthcare visit (other): CT scan
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Breast cancer | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Electrocardiogram QT prolonged | · | · | ✓ |
| SD | Ligament pain | · | · | ✓ |
| SD | Pleural effusion | · | · | ✓ |
| SD | Therapeutic aspiration | · | · | ✓ |
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Flushing | ✓ | ✓ | ✓ |
| SRO | Hypersensitivity | ✓ | ✓ | ✓ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Rash macular | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release